Loading...
Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance
The transcription factor AP-1 is downstream of growth factor (GF) receptors (GFRs) and stress-related kinases, both of which are implicated in breast cancer endocrine-resistance. Previously, we have suggested that acquired endocrine-resistance is associated with increased activity of AP-1 in an in v...
Saved in:
Published in: | Mol Cancer Res |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
2016
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4867274/ https://ncbi.nlm.nih.gov/pubmed/26965145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-15-0423 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|